Literature DB >> 11434624

Vascular endothelial growth factor and liver regeneration.

H Reynaert, M Chavez, A Geerts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11434624     DOI： 10.1016/s0168-8278(01)00081-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  7 in total

1.  Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis.

Authors:  Behrooz K Shamloo; Pankdeep Chhabra; Andrew N Freedman; Arnold Potosky; Jennifer Malin; Sheila Weiss Smith
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

2.  The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure.

Authors:  Tadashi Namisaki; Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Mitsuteru Kitade; Kosuke Kaji; Yusaku Shirai; Yosuke Aihara; Junichi Yoshii; Koji Yanase; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  J Angiogenes Res       Date:  2010-08-24

3.  In vitro interactions between rat bone marrow-derived endothelial progenitor cells and hepatic stellate cells: interaction between EPCs and HSCs.

Authors:  Feng Liu; Zhi-da Liu; Nan Wu; Jiang-Hua Wang; Heng-Hui Zhang; Ran Fei; Xu Cong; Hong-song Chen; Lai Wei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-31       Impact factor: 2.416

4.  Impact of rapamycin on liver regeneration.

Authors:  Daniel Palmes; Andree Zibert; Tymotheus Budny; Ralf Bahde; Evgeny Minin; Linus Kebschull; Jens Hölzen; Hartmut Schmidt; Hans-Ullrich Spiegel
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

5.  Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells.

Authors:  Anming Xiong; Timothy W Austin; Eric Lagasse; Nobuko Uchida; Stanley Tamaki; Bruno B Bordier; Irving L Weissman; Jeffrey S Glenn; Maria T Millan
Journal:  Tissue Eng Part A       Date:  2008-06       Impact factor: 4.080

6.  Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation.

Authors:  P Starlinger; L Alidzanovic; D Schauer; T Maier; C Nemeth; B Perisanidis; D Tamandl; B Gruenberger; T Gruenberger; C Brostjan
Journal:  Br J Cancer       Date:  2012-07-31       Impact factor: 7.640

7.  Combination Therapy of Placenta-Derived Mesenchymal Stem Cells with WKYMVm Promotes Hepatic Function in a Rat Model with Hepatic Disease via Vascular Remodeling.

Authors:  Ji Hye Jun; Sohae Park; Jae Yeon Kim; Ja-Yun Lim; Gyu Tae Park; Jae Ho Kim; Gi Jin Kim
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.